Correction: Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology.

Autor:	Qiao, Wenhui, Chen, Yixing, Zhong, Jun, Madden, Benjamin J., Charlesworth, Cristine M., Martens, Yuka A., Liu, Chia-Chen, Knight, Joshua, Ikezu, Tadafumi C., Aishe, Kurti, Zhu, Yiyang, Meneses, Axel, Rosenberg, Cassandra L., Kuchenbecker, Lindsey A., Vanmaele, Lucy K., Li, Fuyao, Chen, Kai, Shue, Francis, Dacquel, Maxwell V., Fryer, John
Předmět:	AMYLOID PATHOLOGY AMYLOID beta-protein precursor NEURODEGENERATION
Zdroj:	Molecular Neurodegeneration; 4/28/2023, Vol. 18 Issue 1, p1-1, 1p
Abstrakt:	B Correction: Molecular Neurodegeneration 18, 8 (2023) b B https://doi.org/10.1186/s13024-023-00599-3 b The original article [[1]] contained numerous typos and errors which have since been amended. Reference 1 Qiao W, Chen Y, Zhong J, Madden BJ, Charlesworth CM, Martens YA, Liu C-C, Knight J, Ikezu TC, Aishe K, Zhu Y, Meneses A, Rosenberg CL, Kuchenbecker LA, Vanmaele LK, Li F, Chen K, Shue F, Dacquel MV, Fryer J, Pandey A, Zhao N, Bu G. Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.